Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2025 | 7 | $0.29 | $0.33 | $0.31 |
Q2 2025 | 3 | $0.27 | $0.28 | $0.28 |
Q3 2025 | 6 | $0.14 | $0.15 | $0.15 |
Q4 2025 | 5 | $0.18 | $0.18 | $0.18 |
Q1 2026 | 4 | $0.35 | $0.36 | $0.35 |
Q2 2026 | 3 | $0.30 | $0.31 | $0.31 |
Q3 2026 | 2 | $0.16 | $0.16 | $0.16 |
Q4 2026 | 2 | $0.19 | $0.20 | $0.19 |
Elanco Animal Health Incorporated last posted its earnings results on Thursday, November 7th, 2024. The company reported $0.13 earnings per share for the quarter, topping analysts' consensus estimates of $0.12 by $0.01. The company had revenue of 1.03 B for the quarter and had revenue of 4.42 B for the year. Elanco Animal Health Incorporated has generated $-3 earnings per share over the last year ($-2.5 diluted earnings per share) and currently has a price-to-earnings ratio of 28.21. Elanco Animal Health Incorporated has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, February 24th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/07/2024 | Q3 2024 | $0.12 | $0.74 | 0.62 | $1.04 B | $1.03 B |
08/08/2024 | Q2 2024 | $0.24 | -$0.10 | -0.34 | $1.15 B | $1.18 B |
05/08/2024 | Q1 2024 | $0.27 | $0.06 | -0.21 | $1.21 B | |
02/26/2024 | Q4 2023 | $0.10 | -$0.29 | -0.39 | $1.04 B | |
11/07/2023 | Q3 2023 | $0.12 | -$2.22 | -2.34 | $1.04 B | $1.07 B |
08/07/2023 | Q2 2023 | $0.05 | -$0.20 | -0.25 | $1.04 B | $1.06 B |
05/09/2023 | Q1 2023 | $0.29 | $0.21 | -0.08 | $1.26 B | |
03/01/2023 | Q4 2022 | -$0.11 | $988.00 M | |||
11/08/2022 | Q3 2022 | $0.16 | -$0.10 | -0.26 | $1.03 B | $1.03 B |
08/08/2022 | Q2 2022 | $0.26 | -$0.05 | -0.31 | $1.18 B | $1.18 B |
05/09/2022 | Q1 2022 | $0.35 | $0.10 | -0.25 | $1.23 B | |
02/28/2022 | Q4 2021 | -$0.20 | $1.11 B | |||
11/05/2021 | Q3 2021 | $0.17 | -$0.21 | -0.38 | $1.08 B | $1.13 B |
08/09/2021 | Q2 2021 | $0.26 | -$0.43 | -0.69 | $1.24 B | $1.28 B |
05/07/2021 | Q1 2021 | $0.23 | -$0.13 | -0.36 | $1.24 B | |
03/01/2021 | Q4 2020 | -$0.66 | $1.14 B | |||
11/06/2020 | Q3 2020 | $0.12 | -$0.29 | -0.41 | $913.80 M | $889.60 M |
07/30/2020 | Q2 2020 | $0.06 | -$0.13 | -0.19 | $575.44 M | $586.30 M |
05/07/2020 | Q1 2020 | $0.24 | -$0.12 | -0.36 | $657.70 M | |
02/28/2020 | Q4 2019 | -$0.03 | $787.00 M |
Elanco Animal Health Incorporated has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, February 24th, 2025 based off last year's report dates.
In the previous quarter, Elanco Animal Health Incorporated (:ELAN) reported $0.13 earnings per share (EPS) to beat the analysts' consensus estimate of $0.12 by $0.01.
The conference call for Elanco Animal Health Incorporated's latest earnings report can be listened to online.
The conference call transcript for Elanco Animal Health Incorporated's latest earnings report can be read online.
Elanco Animal Health Incorporated (:ELAN) has a recorded annual revenue of $4.42 B.
Elanco Animal Health Incorporated (:ELAN) has a recorded net income of $4.42 B. Elanco Animal Health Incorporated has generated $-2.5 earnings per share over the last four quarters.
Elanco Animal Health Incorporated (:ELAN) has a price-to-earnings ratio of 28.21 and price/earnings-to-growth ratio is 0.24.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED